#bones

Internal documents show Gilead held off on developing new therapies, such as Descovy, a potentially less toxic version of Truvada.

With a $2.4 million grant, researchers will develop a tool to calculate an HIV-positive person’s probability of a fracture.

Truvada and Descovy are both highly effective and generally safe options for HIV prevention.

The single-tablet regimen contains ViiV’s integrase inhibitor dolutegravir and Janssen’s NNRTI rilpivirine.

Taking care of your whole health is just as important as taking care of your HIV.

Unhealthy alcohol use is prevalent in the HIV population and is associated with higher risks for many health problems.

Providers need to stay vigilant to help prevent bone loss.

The prevalence of low bone mineral density (BMD) among HIV-positive gay men is not significantly related to the virus, but caused by other ris...

Lessons learned during the global scale-up of HIV treatment can be used to address epidemics of TB and non-communicable diseases (NCDs).

People living with HIV and hepatitis C virus (HCV) coinfection are more likely to experience a hip fracture as a result of decreased bone mine...

Compared with people living with HIV and not being treated for it, those using antiretroviral (ARV) therapy are less likely to experience...

Two annual doses of Reclast (zoledronate) improved bone health for up five years in a small study involving HIV-positive people with bone mine...

Vitamin D supplementation may help prevent hormonal changes that can lead to bone loss among adolescents and young adults being treated for HI...

People living with or at risk for cardiovascular disease should consider vitamin D supplementation, despite limits in supporting data.

For people living with HIV on public health insurance, the risk of dying is about twice that of those who have private health insurance.